OraSure Technologies, Inc. (NASDAQ:OSUR) Short Interest Up 17.2% in January

OraSure Technologies, Inc. (NASDAQ:OSUR) was the target of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 1,910,000 shares, a growth of 17.2% from the January 15th total of 1,630,000 shares. Based on an average trading volume of 879,000 shares, the short-interest ratio is currently 2.2 days.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered OraSure Technologies from a “buy” rating to a “hold” rating in a research note on Thursday.

Institutional Investors Weigh In On OraSure Technologies

Large investors have recently bought and sold shares of the company. Creative Planning acquired a new position in OraSure Technologies in the third quarter valued at approximately $54,000. Koss Olinger Consulting LLC lifted its holdings in OraSure Technologies by 9.4% in the third quarter. Koss Olinger Consulting LLC now owns 83,977 shares of the medical instruments supplier’s stock valued at $359,000 after acquiring an additional 7,247 shares during the period. Assenagon Asset Management S.A. lifted its holdings in OraSure Technologies by 25.7% in the third quarter. Assenagon Asset Management S.A. now owns 205,559 shares of the medical instruments supplier’s stock valued at $878,000 after acquiring an additional 42,017 shares during the period. Ballentine Partners LLC acquired a new position in OraSure Technologies in the third quarter valued at approximately $159,000. Finally, Principal Financial Group Inc. lifted its holdings in OraSure Technologies by 28.1% in the third quarter. Principal Financial Group Inc. now owns 66,060 shares of the medical instruments supplier’s stock valued at $282,000 after acquiring an additional 14,480 shares during the period. Hedge funds and other institutional investors own 93.50% of the company’s stock.

OraSure Technologies Stock Performance

NASDAQ OSUR traded up $0.04 during trading hours on Friday, reaching $3.93. The stock had a trading volume of 356,731 shares, compared to its average volume of 831,436. The stock has a fifty day moving average of $3.81 and a 200 day moving average of $4.04. The stock has a market cap of $293.14 million, a P/E ratio of 26.20 and a beta of 0.05. OraSure Technologies has a 52-week low of $3.52 and a 52-week high of $8.04.

About OraSure Technologies

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.